Case Study: ADHD Analysis

ADHD is a chronic disorder affecting several children worldwide and proceeds into adulthood. I feel that the case study conducted is beneficial in creating awareness on how to handle the affected and containment measures of this condition. In the U.S, several children suffer from ADHD conditions, and a lot of care needs to be implemented for proper treatment (Caye et al.,2019). I felt that getting the patients' full history and the family was important to the psychiatrist before recommendations of the appropriate medicine for use. According to the case study, DBs' condition is associated with allergies, and the medical recommendation of Zyrtec 5ml (5mg) PO QD PRN was appropriate because allergies are seasonal. Zyrtec is an antihistamine that tends to reduce allergies symptoms, while histamine plays a major role in regulating hyperactive behaviors.

Is your time best spent reading someone else’s essay? Get a 100% original essay FROM A CERTIFIED WRITER!

Order now

On the same note, I felt that the psychiatrist would not have recommended Flinstone MVI QD drug to the patient due to the presence of nutrients added, which may cause metabolic syndrome and gastrointestinal disorders. Also, I feel that using stimulant medication was appropriate for the first medication to give faster behavioral results and ADHD characteristics in children. Sadock et al. (2015) state that Methylphenidate and dextroamphetamine drugs reduce ADHD symptoms in children within 14 months.

ADHD condition is most common in boys than girls and begins at an early stage due to maternal factors, environmental exposure, genetic inheritance, among other factors. Therefore, early diagnosis and treatment reduce the risk factors of the disease before reaching their adulthood. According to the case study, DB inherited the father's condition who had the disease as a child. Also, the mother experiencing stress and migraine headaches is an indication that they share ADHD traits within the family.

I feel that assessing the patients’ progress was important because it is another starting point to determine whether the treatment is going on the expected direction. I understand the psychiatrists’ change in medication by increasing the initial oral dose of Zyrtec from 5mg/day to 10mg/day for its effectiveness. However, using Zyrtec with antidepressants may not be appropriate because it is mostly recommended to use stimulant drugs in children with ADHD to produce a general superior outcome. Following the mother's complaint about the failure of compliance, making changes to the use of antidepressants would be considered for compliance.

There is a need for a psychiatrist to contact the family of DB and the school to monitor his behaviors for target symptoms (Pfiffner & DuPaul,2015). I feel that the mother should not enroll the baby in a private school but rather follow the psychiatrist's information as one of the containment measures of ADHD. The treatment of ADHD requires more knowledge towards the medication behaviors, expected symptoms, collaboration of family members, school, clinicians, among other close relatives. I feel the mother should rely mostly on behavioral change and reactions of DB, which will provide more evidence about the disease, including considerations of other treatments. Jonathan et al. (2017) argue that behavioral strategy will help determine his school performance, relationship with peers, moods, and movements, among other activities.

Family counseling, tie to complete projections, and psychotherapy individuals will help achieve all the long-term goals (Pfiffner & DuPaul,2015). Exercises and engagements with social groups are necessities towards attaining the target responses in the long run. The therapy at home and school will help the psychiatrist examine the patient and know what medication to embark on. Sadock et al. (2015) state that ADHD questionnaires will help obtain more information about the child's characteristics by showing how long the patient has been living with the condition, behaviors that are important for diagnostic purposes.

I understand the need to consider new medication on the patient. The pharmacologic therapy, which includes both current and new medication, will work better for JB. However, using non-stimulant drugs for a start may not be effective since it may result in sudden death combined with Concerta medicine (Jonathan et al.,2017). The use of 18mg/dose concerta every morning as a stimulant is suitable for the patient because it lasts longer, and the child may not require another dose from the school nurse while at school.

I feel that JB is fit for DSM-V criteria before age 12 because it gives a history of ADHD symptoms in several environmental setups to be observed over a period. The major concern is hyperactivity and impulsive, lack of attention, and interrelationships, including school performance (Pfiffner & DuPaul,2015). To achieve DSM-V criteria results, the family should collaborate with teachers to get the behavioral characteristics.

Flinstone MVI medicine sometimes increases the risk of side effects and, therefore, vitamins and nutritional supplements. I feel that the parameters and the methods on your new medication will guide the patient to be aware of the side effects when the medicine is used. On the same note, Flinstone MVI may be dangerous in the presence of Vitamin D, Iron, and Zinc, which can cause nausea (Caye et al. 2019). Flinstone MVI vitamins may also become useless in the presence of vitamin B and vitamin C, which may later soften and develop dark spots. Due to the possibility of dark spots, the patient needs to be under extra care to avoid that occurrence that may interfere with the treatment progress.

References

Caye, A., Swanson, J. M., Coghill, D., & Rohde, L. A. (2019). Treatment strategies for ADHD: an evidence-based guide to select the optimal treatment. Molecular Psychiatry, 24(3), 390-408. "https://www.nature.com/articles/s41380-018-0116-3" https://www.nature.com/articles/s41380-018-0116-3

Jonathan P. Heldt, M., & D, J. P. (2017). Memorable psychopharmacology. Createspace Independent Publishing Platform.

Pfiffner, L. J., & DuPaul, G. J. (2015). Treatment of ADHD in school settings. "https://psycnet.apa.org/record/2014-57877-024" https://psycnet.apa.org/record/2014-57877-024

Sadock, B.J., Sadock, V.A., Ruiz., P (2015). Kaplan and Sadock synopsis of psychiatry (11th ed.). Baltimore, MD: Williams & Wilkins.